Company

Vicebio

Biotechnology Research 23 employees

Employees: 23
Contacts: 3
Emails: 3

www.vicebio.com LinkedIn Crunchbase

Vicebio Overview

Website: www.vicebio.com
Industry: Biotechnology Research
Employees: 23
Founded: 2019
Funding: 100.0M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Vaccines Structural vaccinology respiratory viruses RSV Influenza SARS-Cov-2 Metapneumovirus Parainfluenza

About Vicebio

Vicebio is a clinical-stage biopharmaceutical company developing transformative multi-pathogen vaccines for respiratory viral infections. At the core of our work is Vicebio’s groundbreaking Molecular Clamp Technology, which locks viral proteins in their optimal conformation. This innovation enables our vaccines to deliver a unique combination of broad protection, ready-to-use administration, and convenient manufacturing. Our lead program is a best-in-class multivalent vaccine targeting five respiratory diseases, positioning Vicebio as a leader in multipathogen respiratory vaccines.

Vicebio Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage

Vicebio Org Chart

Sample employees and titles

Name	Title	Location	Contact
Vincent Dodeur		Waremme, Walloon Region, Belgium	Email
Dr Craig Belcher Mba Gaicd Rttp	Head of Life Sciences, Ip Commercialisation @Uniquest	Australia	Email
Koen Huygens			View
Wim Tiest		Geel, Flemish Region, Belgium	Email